The United States Food and Drug Administration granted generally recognized as safe status to baobab dried fruit pulp as a food ingredient in 2009.

In February 2006, ViroPharma announced that the United States Food and Drug Administration (FDA) had granted the company fast track status for maribavir.

The US Food and Drug Administration (FDA) has granted Fast Track review status to apaziquone for this indication.

Recently, the FDA has approved a number of cannabis research clinical trials, but the Drug Enforcement Administration has not granted licenses to the researchers in these studies.

The U.S. Food and Drug Administration granted the agent an accelerated approval on August 19, 2011 for use against these two diseases.

The United States Food and Drug Administration granted an orphan drug designation to Sym001.

Genentech Inc. said the United States Food and Drug Administration had granted orphan drug status for its Dnase drug for treating cystic fibrosis.

The U.S. Food and Drug Administration (FDA) has granted hyperimmune bovine colostrum "orphan drug status."

In 2007, the U.S. Food and Drug Administration (FDA) granted varespladib sodium orphan drug status for its potential to treat patients with sickle-cell disease.

In 2006 the U.S. Food and Drug Administration granted accelerated approval for thalidomide in combination with dexamethasone for the treatment of newly diagnosed multiple myeloma patients.